Skip to content

Author

Sandip Basu

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

[ 68 Ga]Ga-FAPI-04 PET/CT outperforms [ 18 F]FDG-PET/CT in Disease Mapping and Progression Assessment in Metastatic High-Grade Pleomorphic Sarcoma: A Potential for FAPI Theranostics

Abstract Pleomorphic sarcoma is an aggressive soft-tissue malignancy with heterogeneous metabolic characteristics and tumor biology. We herein report a 52-year-old woman with metastatic high-grade pleomorphic sarcoma who underwent dual-tracer imaging with [ 18 F]Fluorodeoxyglucose and [ 68 Ga]Ga-Fibroblast activation p...

M. Mali, S. Sonavane, Sandip Basu · 0 citations
Open access Sep 2026

Combinatorial Treatment Strategy of 177 Lu-PSMA-617 and Docetaxel Chemotherapy in Highly PSMA- and FDG-Avid (Pro-PET Score 3) Metastatic Castration-Resistant Prostate Cancer While Considering Pre-taxane PRLT

Abstract 177 Lu-PSMA-617 targeted radioligand therapy (RLT) received U.S. Food and Drug Administration approval in 2022 for metastatic castration-resistant prostate cancer (mCRPC) patients progressing after androgen receptor pathway inhibitors and taxane chemotherapy. Despite its efficacy, response rates vary, promptin...

Amal Paul, Keerti Sitani, Sandip Basu · 0 citations
Oct 2026

18F-FDG PET/CT Metabolic Patterns in Clinically Probable Seronegative Autoimmune Encephalitis with Normal MRI Findings: A Retrospective Observational Study.

Seronegative autoimmune encephalitis (AIE) poses a significant diagnostic challenge because of the absence of identifiable neuronal antibodies and frequently normal structural neuroimaging. 18F-FDG PET/CT has emerged as a sensitive functional imaging modality for detecting metabolic abnormalities in such patients. We c...

Priyanka Verma, Keerti Sitani, Shilpa D. Kulkarni et al. · 0 citations
Case report Jul 2026

Tuberculosis Mimicking Tumor Progression on Dual-tracer 68Ga-DOTATATE and 18F-FDG PET/CT in Metastatic Neuroendocrine Tumor of Unknown Primary: A Potential Imaging Pitfall in Neuroendocrine Tumor Surveillance.

False-positive findings on molecular imaging can pose significant diagnostic dilemmas in oncological cases. We report an elderly woman with metastatic neuroendocrine tumor of unknown primary who underwent 5 cycles of [177Lu]Lu-DOTATATE PRRT and achieved a partial response. On follow-up, [68Ga]Ga-DOTATATE and [18F]FDG-P...

Rangat Bagasariya, S. Sonavane, Sandip Basu · 0 citations
Review Jul 2026

The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches.

INTRODUCTION Thyroid cancer is the most common endocrine malignancy, and despite advances in understanding its genomic drivers, significant challenges remain in predicting tumor behavior, therapeutic response, and disease progression. This review summarizes advances in transcriptomic profiling and liquid biopsy approac...

Srabonti Ghosh, Avik Chakraborty, Bhakti Basu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.